34 results on '"Abu Hejleh, Taher"'
Search Results
2. Beyond clinical trials: real-world impact of immunotherapy on NSCLC in Jordan
3. Gallium-68-Labeled Fibroblast Activation Protein Inhibitor as an Alternative Radiotracer to Fluorine 18-Fluorodeoxyglucose: A Case Report of Rare Pulmonary Colloid Adenocarcinoma Diagnosed by PET/CT
4. Impact of the Immediate Release of Clinical Information Rules on Health Care Delivery to Patients With Cancer
5. Re-Irradiation for Recurrent Head and Neck Cancer: Freedom from Cancer Recurrence Rate
6. Pharmacological ascorbate improves the response to platinum-based chemotherapy in advanced stage non-small cell lung cancer
7. Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer
8. The Predictive Value of Peripheral Immune Cell Counts for the Presence of Brain Metastases in Stage IV Non-Small-Cell Lung Cancer (NSCLC)
9. Comparison of Two Standard Treatment Approaches in Locoregionally Advanced Nasopharyngeal Carcinoma
10. Brain Metastases from Esophageal Cancer in the Presence of HER-2 Overexpression
11. Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation
12. Abstract CT164: Pharmacological ascorbate enhances platinum-based chemotherapy responses in metastatic non-small cell lung cancer (NSCLC): A phase II clinical trial
13. Phase II trial of atezolizumab (A) + carboplatin (C) + pemetrexed (P) + bevacizumab (B) in pts with stage IV non-squamous non-small cell lung cancer (NSq-NSCLC): Big Ten Cancer Research Consortium Study LUN 17-139.
14. Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer.
15. Narrative review: mesenchymal-epithelial transition inhibitors—meeting their target
16. Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation.
17. The clinical significance of soluble PD-1 and PD-L1 in lung cancer
18. Lobar versus sub-lobar surgery for pulmonary typical carcinoid, a population-based analysis
19. Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti–PD-L1 Immunotherapy Be Administered after Anti–PD-1–Related Immune Toxicities?
20. O2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate
21. O 2 ⋅− and H 2 O 2 -Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate
22. A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer
23. Variation in geographic access to chemotherapy by definitions of providers and service locations: a population-based observational study
24. Surgical management of pulmonary typical carcinoids: A population-based analysis.
25. NEK2 as a prognostic marker and therapeutic target in adenocarcinoma of the lung.
26. Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancer
27. The Effect of Receiving Treatment Within a Clinical Trial Setting on Survival and Quality of Care Perception in Advanced Stage Non–Small Cell Lung Cancer
28. Chemotherapy Use and Surgical Treatment by Receptor Subtype in Node-Negative T1a and T1b Female Breast Cancers, Iowa SEER Registry, 2010- to 2012
29. The effect of body mass index (BMI) on non-small cell lung cancer (NSCLC) mortality.
30. ALK, MET, and HER2 in esophageal adenocarcinoma with signet ring cell morphology.
31. Geographic variation in the adjuvant treatment of NSCLC over time.
32. Comorbidity and survival for patients with advanced-stage non-small cell lung cancer.
33. Incidence and Management of Gastrointestinal Perforation from Bevacizumab in Advanced Cancers
34. Relationship between HER-2 overexpression and brain metastasis in esophageal cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.